Angioedema and maculopapular eruptions associated with carbamazepine administration.
Cutaneous rashes and eruptions can be caused by many medications, including carbamazepine. The presentation can be varied depending on severity. Cutaneous eruptions occur in 3% of individuals administered carbamazepine. Angioedema, a rare side effect of carbamazepine, involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and/or bradykinins. Angioedema is more common in females and in the third decade of life. We report the case of a 27-year-old Indian woman who developed maculopapular rash and angioedema secondary to carbamazepine administration. The patient responded successfully to withdrawal of the drug and treatment with antihistamines. Due to the potentially life-threatening complications of this condition and the increasing use of anticonvulsants in the treatment of mood disorders, psychiatrists must be aware of the diagnosis and treatment of this condition.
Elias
Alby
A
Department of Psychiatry, Jubilee Mission Medical College, Trichur, Kerala, India.
Madhusoodanan
Subramoniam
S
Pudukkadan
David
D
Antony
James T
JT
D000328:Adult; D000799:Angioedema / Q000139:chemically induced*; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D010267:Parapsoriasis / Q000139:chemically induced*; D011618:Psychotic Disorders / Q000188:drug therapy; D011644:Puerperal Disorders / Q000188:drug therapy; D012720:Severity of Illness Index
D000927:Anticonvulsants; D002220:Carbamazepine